DATE: June 15, 2026 at 05:36PM SOURCE: HEALTHCARE INFO SECURITY Direct article link at end of text block below. How # FDA 's Draft Guidance Shapes # AI # Medica
The U.S. Food and Drug Administration (FDA) has released draft guidance concerning the use of artificial intelligence in medical devices. This guidance aims to establish risk controls for evolving AI healthcare tools. Phil Englert of Healthcare Info Security provided an explanation of these proposed controls. AI
IMPACT This guidance will shape the development and deployment of AI in healthcare, influencing safety and risk management protocols for medical devices.